Rezolute, Inc. Common Stock (NV) Stock Prediction
AI-powered sentiment analysis and prediction trends for RZLT, updated each market day.
RZLT AI Sentiment
AI predicts Rezolute, Inc. Common Stock (NV) stock is likely to decrease over the next 10 market days.
Prediction date: Oct. 12, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Rezolute, Inc. Common Stock (NV)
Rezolute Inc is a late-stage rare disease company focused on developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its main clinical asset, Ersodetug, is a potential treatment for refractory hypoglycemia caused by multiple forms of hyperinsulinism. The company has a single reportable segment, which includes all of its activities as a clinical-stage biopharmaceutical company.
Sector
Exchange
Market Cap
$448,791,625
Cap Tier
Employees
58
Headquarters
REDWOOD CITY, CA
Listed Since
Dec. 23, 2011
Website
RZLT Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
RZLT Volatility
Rezolute, Inc. Common Stock (NV) has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
